JOLT — Jolt Health Cashflow Statement
0.000.00%
- CA$1.53m
- CA$1.63m
Annual cashflow statement for Jolt Health, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2020 September 30th | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.325 | -9.52 | -3.58 | -0.766 | -1.17 |
| Amortisation | |||||
| Non-Cash Items | 0.197 | 7.88 | 1.93 | 0.43 | 0.272 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.054 | 0.193 | 0.142 | 0.214 | 0.393 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -0.183 | -1.41 | -1.5 | -0.122 | -0.505 |
| Capital Expenditures | — | -0.161 | — | — | — |
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.352 | -0.008 | -0.81 | 0 | -0.01 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.352 | -0.169 | -0.81 | 0 | -0.01 |
| Financing Cash Flow Items | — | — | — | -0.017 | -0.015 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.54 | 1.38 | 2.02 | 0.083 | 0.514 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.006 | -0.196 | -0.293 | -0.04 | -0.001 |